$1.73
In chiusura: Oct 9 EDT
$1.76
0.031.73%
Pre-mercato: 4:15 AM EDT
Comments
Loading...
Lineage Cell Therapeutics Rapporto sugli interessi allo scoperto
LCTXAMEX
Report sulle vendite allo scoperto
Il short interest su Lineage Cell Therapeutics Inc (AMEX:LCTX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 27.05M a 27.75M. Questo rappresenta il 21.69% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Lineage Cell Therapeutics Corp (XASE:LCTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.31M azioni scambiate al giorno, ci vorrebbero 21.14 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
27.75M
Vendite allo scoperto %
21.7%
Giorni di copertura
21.14
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc | 09/15/2025 | 09/24/2025 | 21.69% | 127,958,752 | 27,748,083 | 1,312,770 | 21.14 | |
LCTX | Lineage Cell Therapeutics, Inc | 08/29/2025 | 09/10/2025 | 21.14% | 127,958,752 | 27,048,226 | 1,349,582 | 20.04 | |
LCTX | Lineage Cell Therapeutics, Inc | 08/15/2025 | 08/26/2025 | 20.91% | 127,958,752 | 26,758,520 | 1,649,868 | 16.22 | |
LCTX | Lineage Cell Therapeutics, Inc | 07/31/2025 | 08/11/2025 | 21.29% | 127,958,752 | 27,236,726 | 1,713,119 | 15.9 | |
LCTX | Lineage Cell Therapeutics, Inc | 07/15/2025 | 07/24/2025 | 21.96% | 127,958,752 | 28,094,805 | 1,737,255 | 16.17 | |
LCTX | Lineage Cell Therapeutics, Inc | 06/30/2025 | 07/10/2025 | 21.68% | 127,958,752 | 27,739,415 | 6,499,752 | 4.27 | |
LCTX | Lineage Cell Therapeutics, Inc | 06/13/2025 | 06/25/2025 | 22.45% | 127,958,752 | 28,728,210 | 2,227,109 | 12.9 | |
LCTX | Lineage Cell Therapeutics, Inc | 05/30/2025 | 06/10/2025 | 22.98% | 127,958,752 | 29,410,740 | 1,328,090 | 22.15 | |
LCTX | Lineage Cell Therapeutics, Inc | 05/15/2025 | 05/27/2025 | 23.42% | 127,958,752 | 29,963,709 | 747,329 | 40.09 | |
LCTX | Lineage Cell Therapeutics, Inc | 04/30/2025 | 05/09/2025 | 20.82% | 144,088,192 | 30,003,557 | 1,108,986 | 27.05 | |
LCTX | Lineage Cell Therapeutics, Inc | 04/15/2025 | 04/25/2025 | 19.73% | 144,088,192 | 28,432,912 | 1,325,716 | 21.45 | |
LCTX | Lineage Cell Therapeutics, Inc | 03/31/2025 | 04/09/2025 | 18.49% | 144,088,192 | 26,641,663 | 2,119,500 | 12.57 | |
LCTX | Lineage Cell Therapeutics, Inc | 03/14/2025 | 03/25/2025 | 15.51% | 144,088,192 | 22,344,067 | 1,522,245 | 14.68 | |
LCTX | Lineage Cell Therapeutics, Inc | 02/28/2025 | 03/11/2025 | 15.29% | 144,042,965 | 22,027,996 | 929,120 | 23.71 | |
LCTX | Lineage Cell Therapeutics, Inc | 02/14/2025 | 02/26/2025 | 14.96% | 144,042,965 | 21,552,750 | 1,318,175 | 16.35 | |
LCTX | Lineage Cell Therapeutics, Inc | 01/31/2025 | 02/11/2025 | 14.79% | 144,042,965 | 21,298,495 | 1,823,637 | 11.68 | |
LCTX | Lineage Cell Therapeutics, Inc | 01/15/2025 | 01/27/2025 | 19.91% | 136,148,228 | 27,108,540 | 3,126,522 | 8.67 | |
LCTX | Lineage Cell Therapeutics, Inc | 12/31/2024 | 01/10/2025 | 14.63% | 177,937,273 | 26,026,548 | 1,928,522 | 13.5 | |
LCTX | Lineage Cell Therapeutics, Inc | 12/13/2024 | 12/24/2024 | 12.89% | 177,937,273 | 22,941,736 | 2,895,143 | 7.92 | |
LCTX | Lineage Cell Therapeutics, Inc | 11/29/2024 | 12/10/2024 | 10.31% | 177,937,273 | 18,342,791 | 5,825,617 | 3.15 | |
LCTX | Lineage Cell Therapeutics, Inc | 11/15/2024 | 11/26/2024 | 9.07% | 177,937,273 | 16,133,922 | 514,684 | 31.35 | |
LCTX | Lineage Cell Therapeutics, Inc | 10/31/2024 | 11/11/2024 | 10.89% | 146,358,322 | 15,938,784 | 447,257 | 35.64 | |
LCTX | Lineage Cell Therapeutics, Inc | 10/15/2024 | 10/24/2024 | 10.77% | 146,358,322 | 15,769,822 | 430,268 | 36.65 | |
LCTX | Lineage Cell Therapeutics, Inc | 09/30/2024 | 10/09/2024 | 10.40% | 146,358,322 | 15,221,739 | 447,297 | 34.03 | |
LCTX | Lineage Cell Therapeutics, Inc | 09/13/2024 | 09/24/2024 | 10.68% | 146,358,322 | 15,630,391 | 270,905 | 57.7 | |
LCTX | Lineage Cell Therapeutics, Inc | 08/30/2024 | 09/11/2024 | 10.81% | 146,358,322 | 15,822,126 | 357,764 | 44.23 | |
LCTX | Lineage Cell Therapeutics, Inc | 07/31/2024 | 08/09/2024 | 9.95% | 146,344,922 | 14,555,849 | 537,297 | 27.09 | |
LCTX | Lineage Cell Therapeutics, Inc | 07/15/2024 | 07/24/2024 | 9.95% | 146,344,922 | 14,563,164 | 666,294 | 21.86 | |
LCTX | Lineage Cell Therapeutics, Inc | 06/28/2024 | 07/10/2024 | 8.83% | 146,344,922 | 12,921,377 | 1,129,865 | 11.44 | |
LCTX | Lineage Cell Therapeutics, Inc | 06/14/2024 | 06/26/2024 | 8.83% | 146,344,922 | 12,917,289 | 808,432 | 15.98 | |
LCTX | Lineage Cell Therapeutics, Inc | 05/31/2024 | 06/11/2024 | 8.38% | 146,344,922 | 12,257,957 | 1,325,983 | 9.24 | |
LCTX | Lineage Cell Therapeutics, Inc | 05/15/2024 | 05/24/2024 | 8.45% | 146,344,922 | 12,369,854 | 1,320,704 | 9.37 | |
LCTX | Lineage Cell Therapeutics, Inc | 04/30/2024 | 05/09/2024 | 7.45% | 146,319,092 | 10,901,781 | 781,899 | 13.94 | |
LCTX | Lineage Cell Therapeutics, Inc | 04/15/2024 | 04/24/2024 | 7.55% | 140,229,027 | 10,582,768 | 1,055,095 | 10.03 | |
LCTX | Lineage Cell Therapeutics, Inc | 03/28/2024 | 04/09/2024 | 7.43% | 139,964,418 | 10,397,492 | 1,171,186 | 8.88 | |
LCTX | Lineage Cell Therapeutics, Inc | 03/15/2024 | 03/26/2024 | 7.13% | 139,964,418 | 9,979,493 | 1,029,069 | 9.7 | |
LCTX | Lineage Cell Therapeutics, Inc | 02/29/2024 | 03/11/2024 | 6.88% | 139,964,418 | 9,623,107 | 497,458 | 19.34 | |
LCTX | Lineage Cell Therapeutics, Inc | 02/15/2024 | 02/27/2024 | 7.17% | 139,909,093 | 10,036,089 | 1,154,271 | 8.69 | |
LCTX | Lineage Cell Therapeutics, Inc | 01/31/2024 | 02/09/2024 | 6.04% | 139,909,093 | 8,455,177 | 588,654 | 14.36 | |
LCTX | Lineage Cell Therapeutics, Inc | 01/12/2024 | 01/24/2024 | 5.95% | 132,517,329 | 7,880,772 | 1,116,494 | 7.06 | |
LCTX | Lineage Cell Therapeutics, Inc | 12/29/2023 | 01/10/2024 | 5.23% | 132,517,329 | 6,935,700 | 713,296 | 9.72 | |
LCTX | Lineage Cell Therapeutics, Inc | 12/15/2023 | 12/27/2023 | 4.64% | 132,517,329 | 6,145,390 | 739,729 | 8.31 | |
LCTX | Lineage Cell Therapeutics, Inc | 11/30/2023 | 12/11/2023 | 4.81% | 132,517,329 | 6,371,280 | 390,258 | 16.33 | |
LCTX | Lineage Cell Therapeutics, Inc | 11/15/2023 | 11/27/2023 | 4.53% | 132,517,329 | 6,007,909 | 524,222 | 11.46 | |
LCTX | Lineage Cell Therapeutics, Inc | 10/31/2023 | 11/09/2023 | 4.64% | 132,517,329 | 6,145,759 | 354,292 | 17.35 | |
LCTX | Lineage Cell Therapeutics, Inc | 10/13/2023 | 10/24/2023 | 4.76% | 132,517,329 | 6,310,314 | 572,976 | 11.01 | |
LCTX | Lineage Cell Therapeutics, Inc | 09/29/2023 | 10/10/2023 | 4.69% | 132,517,329 | 6,216,961 | 346,440 | 17.95 |
In cerca di azioni più vendute allo scoperto?